Tilray Earnings Review

November 14, 2018   |   November 2018 Bond Updates
Tilray Inc. fell over 5% after hours after the Canadian pharmaceutical and cannabis company reported earnings. Tilray lost 20 cents last quarter which missed the Street's estimate for a 14 cent loss.

View more at: https://www.forbes.com/sites/adamsarhan/2018/11/13/tilray-earnings-review/
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/